Review of Bone Scan in Staging of Breast Cancer Patients (Milton Keynes University Teaching Hospital NHS Trust 2020-2021) Volume 2 - Issue 4

Olawunmi Olayiwola¹*, Taiwo O. Aremu^2,3,4, Oluwafemi A Ajibola⁵, Oluwatosin E Oluwole⁶ and Kehinde O Adeyinka⁷

• ¹Department of Medicine, Milton Keynes University Hospital, UK
• ²Masonic Cancer Center, University of Minnesota Masonic Children’s Hospital 420 Delaware St. SE - Mayo MMC 484, USA
• ³Department of Pharmaceutical Care & Health Systems (PCHS), College of Pharmacy, University of Minnesota, USA
• ⁴Division of Environmental Health Sciences, School of Public Health, University of Minnesota, USA
• ⁵Department of Medicine, Nuvance Health, Vassar Brothers Medical Center, USA
• ⁶Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, USA
• ⁷Department of Radiation Oncology, University College Hospital (UCH), Nigeria

Received:December 03, 2021;   Published:December 09, 2021

*Corresponding author: Olawunmi Olayiwola, Department of Medicine, Milton Keynes University Hospital, UK

DOI: 10.32474/CTBM.2021.02.000144

Fulltext PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

We conducted a review of the Milton Keynes University Teaching Hospital NHS Trust’s modality of staging breast cancer to assess compliance with the Royal College of Radiology (RCR) guidelines in the use of bone scan for breast cancer staging. We noticed that a bone scan was required for all breast cancer patients, most of whom did not meet the RCR criteria for a bone scan. We found that a bone scan done on all 89 breast cancer patients seen from June 2020 to May 2021 was ineffective in confirming all cases with bone metastasis, hence not contributing to management and outcomes. We recommend that bone scans should not be routinely done on breast cancer patients, as it is not cost-effective and cost-saving.

Keywords: Breast Cancer; Bone Scan; Whole Body Staging; CT scan; Bone Metastasis

Abbreviations: CT: Computerized Tomography; MRI: Magnetic Resonance Imaging; RCR: Royal College of Radiology; T3: Tumour >4cm but not extending beyond the thyroid gland; T4: Tumour of any size extending beyond the thyroid gland; N1: metastasis to 1 - 3 axillary lymph node or the internal mammary lymph nodes; NHS: National Health Service; USS: Ultrasonography; PET: Positron emission tomography; GBP: British pound sterling

Abstract| Introduction| Review Outcome| Discussion:| Conclusion:| Ethics Approval:| Consent for Publication:| Availability Of Data and Materials:| Competing Interests| Funding| Authors Contributions| Acknowledgment| References|